Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series) - Image 1

£80.00

CRC Press Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Name: Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 80.0 GBP
Availability: InStock

Public Health

Price History & Forecast

Last 80 days • 80 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 80 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £80 (57 days, 71.3%)

Price range: £77 - £80

Price levels: 2 different prices over 80 days

Description

Theory of Drug Development presents a formal quantitative framework for understanding drug development that goes beyond simply describing the properties of the statistics in individual studies. It examines the drug development process from the perspectives of drug companies and regulatory agencies. By quantifying various ideas underlying drug development, the book shows how to systematically address problems, such as: Sizing a phase 2 trial and choosing the range of p-values that will trigger a follow-up phase 3 trial Deciding whether a drug should receive marketing approval based on its phase 2/3 development program and recent experience with other drugs in the same clinical area Determining the impact of adaptive designs on the quality of drugs that receive marketing approval Designing a phase 3 pivotal study that permits the data-driven adjustment of the treatment effect estimate Knowing when enough information has been gathered to show that a drug improves the survival time for the whole patient population Drawing on his extensive work as a statistician in the pharmaceutical industry, the author focuses on the efficient development of drugs and the quantification of evidence in drug development. He provides a rationale for underpowered phase 2 trials based on the notion of efficiency, which leads to the identification of an admissible family of phase 2 designs. He also develops a framework for evaluating the strength of evidence generated by clinical trials. This approach is based on the ratio of power to type 1 error and transcends typical Bayesian and frequentist statistical analyses.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 1466507462
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues > Public Health
Domain: Amazon UK
Release Date: 24 October 2013
Listed Since: 13 February 2012

Barcode

No barcode data available

CRC Press Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

Drug Information: A Guide for Pharmacists, Fourth Edition

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Mathematical and Statistical Skills in the Biopharmaceutical Industry: A Pragmatic Approach

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Signal Detection for Medical Scientists: Likelihood Ratio Test-based Methodology (Chapman & Hall/CRC Biostatistics Series)

Adaptive Design Methods in Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Sample Size Calculations in Clinical Research (Chapman & Hall/CRC Biostatistics Series)

Drug Control and International Law (Routledge Research in International Law)

Fundamentals of Early Clinical Drug Development: From Synthesis Design to Formulation

Converging Pharmacy Science and Engineering in Computational Drug Discovery (Advances in Healthcare Information Systems and Administration)

Fundamentals of Clinical Trials

The Science and Business of Drug Discovery: Demystifying the Jargon

Fundamentals of Decentralized Clinical Trials: Strategy and Execution

Global Issues in Pharmaceutical Marketing

Monte Carlo Simulation for the Pharmaceutical Industry: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

Exploring Medical Statistics: Biostatistics, Clinical Trials, and Epidemiology

Angewandte klinische Pharmakologie: Phase-I-Prüfungen: 214 (Heidelberger Taschenbücher, 214)

Pharmacokinetics in Drug Development: Problems and Challenges in Oncology, Volume 4

Uncertainty in Pharmacology: Epistemology, Methods, and Decisions: 338 (Boston Studies in the Philosophy and History of Science, 338)

Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)

Databases for Pharmacoepidemiological Research (Springer Series on Epidemiology and Public Health)

Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs